이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Multimodal LLM for Breast Cancer Radiotherapy Target Auto-Contouring and Planning

2026년 11월 11일 업데이트: Xiaohui Zhao

Multimodal Data Fusion-Based Artificial Intelligence Large Language Model for Automated Target Volume Contouring and Intelligent Treatment Planning in Breast Cancer Radiotherapy: A Multicenter Ambidirectional Cohort Study

Breast cancer remains the most prevalent malignancy among women worldwide, with a continuously increasing incidence. As a crucial component of comprehensive cancer treatment, radiotherapy plays a key role in reducing local recurrence rates and improving overall survival outcomes. However, traditional radiotherapy target volume contouring and treatment planning design rely heavily on clinician expertise, presenting challenges such as prolonged processing time, significant inter-observer variability, and high subjectivity in dose optimization. Although artificial intelligence has made substantial progress in automated contouring and planning, conventional single-modal models still face major limitations. These models struggle to effectively integrate clinical text, tumor biological characteristics, and dose distribution factors, resulting in restricted generalizability. Therefore, developing an intelligent radiotherapy assistance system capable of multimodal data fusion is of high clinical significance to enhance precision and efficiency in breast cancer radiotherapy.

This study aims to develop an innovative breast cancer radiotherapy assistance system based on a multimodal large language model. By integrating multimodal imaging data (including CT, MRI, and ultrasound), pathology reports, and structured electronic health record text, the system realizes end-to-end intelligence from target volume contouring to treatment plan generation. Employing a multicenter, ambidirectional cohort design, the study collects comprehensive clinical data from breast cancer patients who have undergone breast-conserving surgery or mastectomy. Technologically, the system innovatively combines the natural language processing capabilities of large language models with the image analysis strengths of deep learning, utilizing attention mechanisms to achieve deep fusion and interactive comprehension of heterogeneous medical data. Notably, the system breaks through traditional radiotherapy planning workflows by jointly optimizing target contouring and dose planning as a unified pipeline, applying reinforcement learning algorithms to dynamically balance target volume coverage with organ-at-risk protection. The outcomes of this study will provide an important paradigm for the clinical application of AI in radiation oncology and advance the field of precision radiotherapy.

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

연구 유형

관찰

등록 (추정된)

51000

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Guangdong
      • Guangzhou, Guangdong, 중국, 510120
        • Sun Yat-sen Memorial Hospital, Sun Yat-sen University
        • 연락하다:
        • 수석 연구원:
          • Xiaohui Zhao, MD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

The study population includes patients with breast cancer from multiple medical centers. The retrospective cohort comprises patients treated at Sun Yat-sen Memorial Hospital (n=35,000) and external collaborating centers (Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Zhoukou Central Hospital, and Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, n=15,000) between January 1, 2002, and October 31, 2025. The prospective test cohort comprises patients prospectively enrolled at Sun Yat-sen Memorial Hospital starting from January 1, 2026 (n=1,000).

설명

Inclusion Criteria:

  • Patients with pathologically confirmed breast malignant tumors who require postoperative adjuvant radiotherapy following radical surgery.
  • Availability of complete pathology reports.
  • Availability of complete imaging examinations and reports (such as CT, MRI, ultrasound, X-ray).
  • Availability of standardized clinical medical records.

Exclusion Criteria:

  • Patients with missing data.
  • Patients with primary multiple cancers.
  • Patients receiving salvage or palliative radiotherapy.
  • Patients receiving accelerated partial breast irradiation (APBI).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: OTHER

코호트 및 개입

그룹/코호트
개입 / 치료
Retrospective Training and Internal Validation Cohort

Retrospective collection of clinical data, multimodal images (MRI, CT, ultrasound, X-ray), pathology reports, and radiotherapy plans from patients with breast cancer treated at Sun Yat-sen Memorial Hospital between January 1, 2002, and October 31, 2025. This cohort (n=35,000) is used for model training and internal validation of the multimodal LLM-assisted automated contouring and radiotherapy planning system.

The study evaluates an innovative multimodal large language model (LLM) system designed for automated target volume delineation and intelligent treatment planning in post-operative breast cancer radiotherapy. The system integrates clinical text, multimodal imaging (CT, MRI, ultrasound, X-ray), and pathology data to joint-optimize contouring and dose planning without direct patient intervention.

Retrospective External Validation Cohort

Retrospective collection of data from external collaborative centers (Sun Yat-sen Memorial Hospital Shenzhen Hospital, Zhoukou Central Hospital, and Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) between January 1, 2002, and October 31, 2025 (total n=15,000). This cohort is used to evaluate the external generalizability and robustness of the multimodal AI model.

The study evaluates an innovative multimodal large language model (LLM) system designed for automated target volume delineation and intelligent treatment planning in post-operative breast cancer radiotherapy. The system integrates clinical text, multimodal imaging (CT, MRI, ultrasound, X-ray), and pathology data to joint-optimize contouring and dose planning without direct patient intervention.

Prospective Test Cohort

Prospective collection of data from patients with breast cancer treated at Sun Yat-sen Memorial Hospital starting from January 1, 2026 (n=1,000). This cohort undergoes double-blind evaluation to prospectively test the performance of the multimodal LLM-driven target volume auto-segmentation and intelligent radiotherapy planning system in clinical practice.

The study evaluates an innovative multimodal large language model (LLM) system designed for automated target volume delineation and intelligent treatment planning in post-operative breast cancer radiotherapy. The system integrates clinical text, multimodal imaging (CT, MRI, ultrasound, X-ray), and pathology data to joint-optimize contouring and dose planning without direct patient intervention.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Dice Similarity Coefficient (DSC) of Target Volume Auto-Segmentation
기간: Baseline

Evaluation of the Dice Similarity Coefficient (DSC) between AI-generated automatic breast cancer target volume contours and expert manual contours.

Baseline

2차 결과 측정

결과 측정
측정값 설명
기간
95% Hausdorff Distance (95HD) of Target Volume Auto-Segmentation
기간: Baseline

Evaluation of the 95% Hausdorff Distance (95HD) between AI-generated automatic breast cancer target volume contours and expert manual contours.

Baseline
Intersection over Union (IoU) of Target Volume Auto-Segmentation
기간: Baseline

Evaluation of the Intersection over Union (IoU) between AI-generated automatic breast cancer target volume contours and expert manual contours.

Baseline
Clinical Evaluation Score of Target Volume Auto-Segmentation
기간: Baseline

Blinded evaluation by radiation oncology experts using the Investigator-Developed Cancer Target Volume Contouring Performance Evaluation Scale, a structured 5-point clinical evaluation scale. The scale assesses five dimensions: laterality accuracy (0 to 1 point), radiotherapy type suitability (0 to 1 point), target volume definition (0 to 1.5 points), coverage (0 to 1 point), and structural integrity (0 to 0.5 points). The total score ranges from a minimum of 0 to a maximum of 5, where higher scores indicate better target volume contouring quality and clinical acceptability.

Baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Xiaohui Zhao, MD, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 9일

기본 완료 (추정된)

2027년 12월 1일

연구 완료 (추정된)

2027년 12월 31일

연구 등록 날짜

최초 제출

2026년 11월 2일

QC 기준을 충족하는 최초 제출

2026년 11월 11일

처음 게시됨 (실제)

2026년 11월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 11일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • SYSKY-2026-014-01

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .